Related references
Note: Only part of the references are listed.Subjective expectations regarding length and health-related quality of life in Hungary: results from an empirical investigation
Marta Pentek et al.
HEALTH EXPECTATIONS (2014)
Chronic disease influences over 40 major life-changing decisions (MLCDs): a qualitative study in dermatology and general medicine
Z. U. Bhatti et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2014)
Subjective health expectations at biological therapy initiation: a survey of rheumatoid arthritis patients and rheumatologists
Marta Pentek et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2014)
Cost-of-illness in patients with moderate to severe psoriasis: a cross-sectional survey in Hungarian dermatological centres
Orsolya Balogh et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2014)
Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary
Emese Heredi et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2014)
Health-related Quality of Life in Psoriasis: Important Role of Personal Resources
Joanna Miniszewska et al.
ACTA DERMATO-VENEREOLOGICA (2013)
Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study
O. Ahlehoff et al.
JOURNAL OF INTERNAL MEDICINE (2013)
Switch to Biological Agent in Psoriasis Significantly Improved Clinical and Patient-Reported Outcomes in Real-World Practice
Jenny M. Norlin et al.
DERMATOLOGY (2012)
Definition of treatment goals for moderate to severe psoriasis: a European consensus
U. Mrowietz et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2011)
Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the UK
K. Abuabara et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Conversations on psoriasis - what patients want and what physicians can provide: A qualitative look at patient and physician expectations
Elizabeth E. Uhlenhake et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2010)
What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature
V. Bronsard et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2010)
Once-Weekly Administration of Etanercept 50 mg Improves Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis
Kristian Reich et al.
DERMATOLOGY (2009)
Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis
T. A. Luger et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)
Long-term prognosis in patients with psoriasis
W. Gulliver
BRITISH JOURNAL OF DERMATOLOGY (2008)
Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis
D. Revicki et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
The risk of mortality in patients with psoriasis - Results from a population-based study
Joel M. Gelfand et al.
ARCHIVES OF DERMATOLOGY (2007)
Adalimumab treatment is associated with improvement in health-related quality of life in psoriasis: Patient-reported outcomes from a Phase II randomized controlled trial
Richard Shikiar et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2007)
The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study
Richard Shikiar et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2006)
Expectations regarding length and health related quality of life: Some empirical findings
WBF Brouwer et al.
SOCIAL SCIENCE & MEDICINE (2005)
10 years experience of the Dermatology Life Quality Index (DLQI)
V Lewis et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2004)
Quality of life in patients with psoriasis: A systematic literature review
J de Korte et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2004)
Share Paper
